Heyu Biological Technology Corp. operates as a shell company. The company was founded on May 18, 1987 and is headquartered in Xiamen City, China.
Company profile
Ticker
HYBT
Exchange
CEO
Siong Ang Ban
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
Heyu Biological Technology Corp, PACIFIC WEBWORKS INC
SEC CIK
Corporate docs
Subsidiaries
Hong Chang Global Investment Holdings Limited • Hong Chang Biotechnologies (HK) Limited • Fujian Hongjin Biotechnology Co, Ltd. • Fuqing Hongchang Global Import Export Co., Ltd. • Fuqing Hongchang Food Co., Ltd. • Fuqing Hongchang Global Logistics Co., Ltd. • Fujian Hongchang Global Food Co., Ltd. • Hongchang Global (Fuqing) Agritech Development Co., Ltd. ...
IRS number
870627910
HYBT stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
8-K
Departure of Directors or Certain Officers
1 Apr 24
8-K
Other Events
28 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
24 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
DEF 14C
Information statement
25 Oct 23
PRE 14C
Preliminary information
10 Oct 23
8-K
Entry into a Material Definitive Agreement
7 Sep 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 863.12 k | 863.12 k | 863.12 k | 863.12 k | 863.12 k | 863.12 k |
Cash burn (monthly) | (no burn) | (no burn) | 49.58 k | 50.27 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 330.29 k | 334.87 k | n/a | n/a |
Cash remaining | n/a | n/a | 532.83 k | 528.25 k | n/a | n/a |
Runway (months of cash) | n/a | n/a | 10.7 | 10.5 | n/a | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Sep 23 | Ang Ban Siong | Common Stock | Sell | Dispose S | No | No | 0.001 | 28,328,194 | 28.33 k | 56,011,747 |